BeBetter Med
Latest round
- Series A
Last raised
- May 2020
Total raised
- Undisclosed
Investors
- 3
About BeBetter Med
Founded in 2012 and based in Guangzhou, China, BeBetter Med Inc. operates as a pharmaceutical company which focuses on molecular science and cancer treatment. The chairman and general manager Dr. Changge Qian is the postdoctoral fellow at the National Academy of Sciences, he served as the vice president of Curis, Inc. and obtained more than 40 authorized patents in the United States and more than 20 authorized patents in China, published 37 international invention patents and more than 30 academic papers., Ltd.78 per share at Shanghai Stock Exchange, under the ticker "688759". The company self-developed products include breast cancer, lung cancer, colon cancer inhibitor BEBT-908, breast cancer inhibitor BEBT-209, mutant lung cancer inhibitor BEBT-109, autoimmune disease inhibitor ZXBT-1158, psoriasis inhibitor BEBT-305, mutant non Small cell lung cancer, colorectal cancer inhibitor BEBT-607, non-alcoholic steatohepatitis inhibitor BEBT-503 and diabetes and obesity inhibitor BEBT-808. The company generates revenue by doing research, development and providing innovative small-molecule drugs for tumors, cancer and other related products.
Who invested in BeBetter Med
3 investors across 1 round
See all investors in BeBetter Med
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
May 18, 2020
Amount
Undisclosed
Investors
Questions about BeBetter Med
Who invested in BeBetter Med?
BeBetter Med has 3 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has BeBetter Med raised?
BeBetter Med has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did BeBetter Med last raise money?
BeBetter Med's most recent round on record is a Series A, in May 2020.
What does BeBetter Med do?
Founded in 2012 and based in Guangzhou, China, BeBetter Med Inc.
Where is BeBetter Med headquartered?
BeBetter Med is headquartered in Guangzhou, China.
Which VCs invest in companies like BeBetter Med?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back pharmaceuticals companies at BeBetter Med's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series A
Raising like BeBetter Med? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.